🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well ixazomib citrate, lenalidomide, dexame...
Status
Completed
Location
Mayo Clinic
Start Date
2017-04-20
Trial ID
NCT03012880
The purpose of this study is to characterize the safety and tolerability of...
Status
Terminated
Location
Multiple Locations
Start Date
2014-06-09
Trial ID
NCT02176486
This phase I/II trial studies the side effects and best dose of clarithromy...
Status
Active Not Recruiting
Location
University of California San Diego
Start Date
2015-10
Trial ID
NCT02542657
Treatments Being Tested
The purpose of this study is to investigate the real world effectiveness an...
Status
Completed
Location
Takeda Selected Site
Start Date
2018-04-02
Trial ID
NCT03433001
Treatments Being Tested
A randomized Phase II clinical trial will be conducted to assess the impact...
Status
Active Not Recruiting
Location
Northern Light Eastern Maine Medical Center
Start Date
2020-10-21
Trial ID
NCT04009109
Treatments Being Tested
This phase II trial studies how well ixazomib citrate, lenalidomide, and de...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2016-10-31
Trial ID
NCT02921893
Treatments Being Tested
The main purpose of this study is to collect additional safety information ...
Status
Completed
Location
Anhui Cancer Hospital
Start Date
2020-05-18
Trial ID
NCT04328662
Multiple myeloma is an incurable hematological malignancy that affects olde...
Status
Terminated
Location
CHU CAEN Dept of Hematology
Start Date
2019-02-07
Trial ID
NCT03757221
Treatments Being Tested
This phase II trial studies how well ixazomib citrate and lenalidomide afte...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2012-12-03
Trial ID
NCT01718743
Treatments Being Tested
The purpose of this study is assess safety, safest dose, and effectiveness ...
Status
Active Not Recruiting
Location
Boston Medical Center
Start Date
2022-10-26
Trial ID
NCT05451771